Autoantibodies against a kidney-liver protein associated with quinolone-induced acute interstitial nephritis or hepatitis

Nephrology Dialysis Transplantation

Volumn 12, Issue 9, 1997, Pages 1961-1962

  Gauffre, A ^a   Mircheva, J ^a   Glotz, D ^b   Fillastre, J P ^c   Simon, P ^d   Beaune, P H ^a   Druet, P ^b  

^a INSERM   (France)

^b HÔPITAL BROUSSAIS   (France)

^c Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^d Centre Hospitalier de Saint Brieuc   (France)

Author keywords

Acute interstitial nephritis; Autoantibodies; Hepatitis; P 450; Quinolone

Indexed keywords

AUTOANTIBODY; QUINOLONE;

ARTICLE; AUTOIMMUNITY; CASE REPORT; CONTROLLED STUDY; HEPATITIS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INTERSTITIAL NEPHRITIS; KIDNEY; LIVER MICROSOME; PRIORITY JOURNAL;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; AUTOANTIBODIES; BIOLOGICAL MARKERS; HEPATITIS, TOXIC; HUMANS; IMMUNOBLOTTING; KIDNEY; LIVER; MICROSOMES; NEPHRITIS, INTERSTITIAL; PROTEINS; QUINOLONES;

EID: 0030766724     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.9.1961     Document Type: Article

References (13)

1. Nessi R, Bonoldi GL, Redaelli B, Di Filippo G. Acute renal failure after rifantin: a case report and survery of the literature. Nephron 1976; 16: 148
2. Rippelmeyer DJ, Synhavsky A. Ciprofloxacin and allergic interstitial nephritis. Ann Intern Med 1988; 109: 170
3. Grassmick BK, Lehr VT, Sundareson AS. Fulminant hepatic failure possibly related to ciprofloxacin. Ann Pharmacol Ther 1992; 22: 636-639
4. Pruna A, Akposso K, Bedrossian J et al. Peflacine as first-line treatment in nephrotic syndrome. Lancet 1992; 340: 728-729, L
5. Kremers P, Beaune P, Cresteil T et al. Cytochrome p-450 monooxygenase activity in human and rat liver microsomes. Eur J Biochem 1981; 118: 599-605
6. Siddile ZH, Minnaugh EG, Trush MA, Gram TE. The effect of vitamin A deficiency on hepatic, real and pulmonary glutathione S-transferase activities in the rat. Biochem J 1980; 88: 889-893
7. Guengerich FP, Dannan GA, Wright St, Martin Mv, Kaminsky LS. Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or b-naphtoflavone. Biochemistry 1982; 21: 6019-6031
8. Bourdi M, Larrey D, Nataf J et al. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-4501A2 specific marker of dihydralazine-inducèd hepatitis. J Clin Invest 1990; 85:1967-1973
9. Riley RJ, Smith G, Wof CR, Cook VA Leeder JS. Human anti-endoplasmic reticulum autoantibodies produced in aromatic anticonvulsant hypersensitivity reactions recognise rodent cyp3A proteins and a similarly regulated human P450 enzyme(s). Biochem Biophys Res Commun 1993; 191: 32-40
10. Beaune PH, Dansette PM, Mansuy D et al. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P450 that hydroxylates the drug. Proc Natl Acad Sci USA 1987; 84: 551-555
11. Beaune P. Pessayre D, Dansette P, Mansuy D, Manns M. Autoantibodies against cytochromes P450: role in human diseases. Adv Pharmacol 1994; 30: 199-245
12. Lecoeur S, Bonierbale E, Chaline D et al. Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: Comparison with two directly hepatotoxic drugs Chem Res Toxicol 1994; 7: 434-442
13. Bourdi M, Gautier JC, Mircheva J et al. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis. Specificity of autoantibodies and inductive capacity of the drug. Mol Pharmacol 1992; 42: 280-285